Cost of UK’s drug price deal with US will come out of NHS budget
The cost of the government’s drug pricing deal with the Trump administration will come out of the NHS budget instead of the Treasury’s and could eventually reach £9bn a year, campaigners fear.Patrick Vallance, the science minister, has confirmed that the costs – initially an extra £1bn over three years– will be borne by the Department of Health and Social Care, which funds the NHS in England, and not the Treasury.His admission, in a letter to the Commons science, innovation and technology committee, is the first time the government has specified which Whitehall department would foot the bill.It comes amid growing concern among Labour, Liberal Democrat, Green and Scottish National party MPs that ministers have been evasive about the costs involved and risk that the NHS may have to cut services in order to pay the 25% higher prices for new drugs that ministers agreed to.The £1bn is the estimated extra cost for the first three years of the 10-year deal the government announced on 1 December.
The extra spending needed by 2035, when the deal ends, could be as much as £9bn each year, campaigners have said,The Lib Dems have criticised the agreement as a Trump shakedown of the NHS and “just a desperate ploy to placate Trump” by the prime minister, Keir Starmer,The deal applies only to newly developed medicines and not to established generic drugs, which make up most of the NHS’s £20bn annual spending on pharmaceuticals,In his letter to the committee, Vallance said the DHSC, NHS England and the National Institute for Care and Health Excellence had undertaken a joint analysis of the deal’s costs,“Overall, the combined analysis is that the deal commitments will cost about £1bn in England over the remaining three years of the spending review.
” That period is until the end of March 2029.Vallance sought to calm fears about the NHS’s budget being used to pay for more expensive drugs by stressing that “this deal will be funded by allocations made to DHSC at the spending review, where frontline services will remain protected through the record funding secured.”Dr Layla McCay, the director of policy at the NHS Confederation and NHS Providers, warned that cuts were inevitable and said that NHS trust bosses “will be concerned to note that against an already very challenging financial environment DHSC budgets will be used”.She added: “It also remains unclear which planned DHSC spending will need to be cut to cover the costs of higher medicines spending.”The best public interest journalism relies on first-hand accounts from people in the know.
If you have something to share on this subject, you can contact us confidentially using the following methods:The Guardian app has a tool to send tips about stories.Messages are end to end encrypted and concealed within the routine activity that every Guardian mobile app performs.This prevents an observer from knowing that you are communicating with us at all, let alone what is being said.If you don’t already have the Guardian app, download it (iOS/Android) and go to the menu.Select ‘Secure Messaging’.
Our guide at theguardian.com/tips lists several ways to contact us securely, and discusses the pros and cons of each.The government has agreed as part of the deal to double the UK’s spending on all drugs by 2035 from 0.3% to 0.6% of GDP but has not given any figures as to how much that will cost.
Tim Bierley, of Global Justice Now, said that despite Vallance’s letter, ministers were still refusing to set out how much the government will have to pay for drugs in the long term.“It’s incredible that ministers continue to hide behind the short-term costs of this deal when they know the bill will grow every year.Doubling spending on medicines as a percentage of GDP … would mean an additional £9bn a year by 2035.“The government must come clean about the true costs of this deal, change course and stand up to corporate interests working with Trump to loot our health system.”Vallance was responding to a demand from Chi Onwurah, the chair of the committee, for greater clarity on the costs of the deal.
“This deal carried a significant cost and it’s up to the government to ensure that it delivers significant return”, she said,“It’s crucial that the benefits to UK patients outweigh the projected financial cost, particularly given the huge existing demands on the NHS,”
Cyber-attack and yacht insurer agrees £8bn deal in latest UK stock market exit
A British company specialising in insuring against cyber-attacks that also covers fine art and luxury yachts has agreed to be taken over in an £8bn deal, in what would be the latest loss to the London stock market.Beazley said on Wednesday it had agreed the deal with its larger rival Zurich, after the Switzerland-listed company raised its bid for the Lloyd’s of London insurer.The two companies said in a joint statement that they had reached an “agreement in principle” on the main financial terms, under which Beazley shareholders will get up to £13.35 for every share they hold. This includes an offer price of £13
Drax insiders privately raised concerns over its sustainability claims, court papers show
Senior executives at Drax raised concerns internally about the validity of the energy company’s sustainability claims while it publicly denied allegations that it was cutting down environmentally important forests for fuel, court documents have revealed.Britain’s biggest power plant assured ministers and civil servants of the company’s green credentials as it scrambled to defend itself against claims in a BBC Panorama documentary that it had burned wood sourced from “old-growth” forests in Canada.The company’s senior leaders, including its chief executive, publicly denied the allegations, but other executives at the North Yorkshire plant privately raised concerns that it did not have sufficient evidence to back up the sustainability claims, according to evidence submitted to an employment tribunal involving its former top lobbyist.The owners of Drax have received more than £7bn in subsidies levied on household energy bills on the condition that the biomass pellets are made from waste or low-value wood from sustainable forests.However, the company has faced repeated scepticism over the sustainability of its business model, which involves importing millions of tonnes of wood pellets across the Atlantic every year
UK services sector job cuts continue as companies automate, PMI survey shows
Companies in the UK’s services sector cut jobs last month, as they turned to “automation” rather than hiring new staff, a closely watched survey showed.The monthly purchasing managers’ index showed employment numbers fell more sharply in January compared with December, continuing a trend that started in October 2024.The PMI survey, which is considered to be one of the most reliable indicators of how a sector is performing, said this was the “longest period of job shedding” in the UK services sector in 16 years, with firms also choosing not to replace voluntary leavers.The survey compiled by S&P Global said anecdotal evidence suggested some companies were turning to automation to make up for the staffing shortfall and increase productivity, alongside squeezed margins and fragile market conditions also affecting hiring decisions.Tim Moore, the economics indices director at S&P Global Market Intelligence, said: “There were again gloomy signals for the UK labour market outlook as staff hiring decreased at a steeper pace in January as firms looked to offset rising payroll costs
Striking Starbucks workers urge customers to delete coffee chain’s app
Striking Starbucks baristas are calling on customers of the world’s largest coffee chain to delete its popular mobile app in solidarity with their demands for a first union contract.Starbucks Workers United, which has been coordinating a strike for almost three months, is vowing to press ahead.“We baristas are still fighting for a fair contract, and this fight is active and ongoing,” said KC Ihekwaba, a barista at Starbucks in Lafayette, Colorado, on a solidarity union call earlier this week. “Our fire for change is still burning. Our spirits still strong
Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026
The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to what its boss described as a “painful” push by Donald Trump to lower US weight-loss drug prices, rising competition, and the loss of important patent protections.Denmark’s Novo, once the poster-child for the growth in weight-loss treatments, said sales this year were likely to fall between 5% and 13%, ending years of double-digit gains, despite the promising launch of its new Wegovy pill in the US.Its share price plummeted 17% on Wednesday, erasing all gains so far this year. In the past year the stock has lost nearly 50% of its value.Last year, Novo’s total sales grew by 10% to 309bn Danish kroner (£36
Santander takes fresh swipe at City watchdog as its car loan scandal bill tops £460m
Santander has accused the City watchdog of overreach after its bill for the UK motor finance scandal reached £461m, as the Spanish lender signed a $12bn takeover of an American bank.The bank – which announced the surprise takeover of US-based Webster Bank on Tuesday night – took a fresh swipe at the Financial Conduct Authority (FCA) on Wednesday over a compensation scheme for the scandal.Santander UK had been concerned over what it claimed was a lack of clarity around the regulator’s plans for an £11bn redress scheme, which was meant to draw a line under the ballooning motor finance scandal.Santander said on Wednesday it had put aside a further £183m to compensate drivers who were overcharged via unfair commission arrangements between lenders and car dealers.However, the bank said this was based on the FCA’s proposals for payouts, which it criticised for going too far
PE funding and the true cost of obesity | Letter
Pentagon threatens to cut ties with Scouting America over ‘core values’
Three-quarters of cancer patients in England will survive by 2035, government pledges
Cost of UK’s drug price deal with US will come out of NHS budget
Ministers to crack down on profiteering in care sector and make renewed fostering push
Council and community could join up on housing | Letters